rolipram has been researched along with Pneumonia, Viral in 1 studies
Pneumonia, Viral: Inflammation of the lung parenchyma that is caused by a viral infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Inflammation is generally accepted as a component of the host defence system and a protective response in the context of infectious diseases." | 2.66 | Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19? ( Pinho, V; Sousa, LP; Teixeira, MM, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sousa, LP | 1 |
| Pinho, V | 1 |
| Teixeira, MM | 1 |
1 review available for rolipram and Pneumonia, Viral
| Article | Year |
|---|---|
Harnessing inflammation resolving-based therapeutic agents to treat pulmonary viral infections: What can the future offer to COVID-19?
Topics: Acetates; Angiotensin I; Animals; Annexin A1; Anti-Inflammatory Agents; COVID-19; COVID-19 Drug Trea | 2020 |